Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Mega Financial (2886.TW)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (NT$)	Price Target (NT$)	Rating
2022-02-16	37.09	31.748	Neutral
2022-04-12	43.16	-	No Rating
2022-06-15	35.15	29.32	Sell
2022-09-28	31.02	27.282	Sell
2023-01-16	31.07	26.019	Sell
2023-03-22	31.75	26.408	Sell
2023-09-11	35.15	27.67	Sell
2023-11-29	38.01	28.35	Sell
2023-12-13	37.77	29.612	Sell
2024-03-19	39.03	30.485	Sell
2024-06-05	38.01	32.52	Sell
2024-09-20	39.35	32.20	Sell

Disclosures

This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-investment banking securities-related services are being, or have been, provided.
This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-securities services are being, or have been, provided.
Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
UBS holds a long or short position of 0.5% or more of the listed shares of this company.

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.